Objectives: To examine all-cause and cause-specific mortality over a 15-year follow-up
period in relation to at-baseline reported lifetime use of illegal drugs from five classes …

Objective The purpose of this study was to determine the mortality risks, over 20 years of
follow-up in a nationally representative sample, associated with illegal drug use and to …

This study examines the sociodemographic determinants of psychoactive drug–related
mortality in the United States, using data from the National Health Interview Survey (1987 …

Abstract Background and Aims During the past decades, people who inject drugs (PWID)
have been impacted by the development of combination antiretroviral therapy (cART) to …

Background In contrast to research on more restricted samples of drug users,
epidemiological studies open up a view of death rates and survivorship of those who have …

PURPOSE: To estimate and compare prevalence rates of lifetime health conditions by
inferred duration of illicit drug use among the general US adult population and to investigate …

Estimating mortality directly attributable to illicit drug use such as overdose death—the most
tangible adverse heath effect of illicit drug use—is difficult because of variations in the …

ABSTRACT BACKGROUND For adults in general population community settings, data
regarding long-term course and outcomes of illicit drug use are sparse, limiting the …

Objective: To determine the incidence of mortality of injecting drug users as a function of the
duration of injecting drugs and HIV status, and to assess how these effects vary according to …

A number of unique challenges are faced when attempting to estimate mortality attributable
to illicit drugs. The hidden nature of illicit drug use creates difficulties in quantifying the …